Shajari, Mehdi
Rusev, Vladimir
Mayer, Wolfgang
Diakonis, Vasilios
Petermann, Kerstin
Kohnen, Thomas http://orcid.org/0000-0002-6933-9585
Article History
Received: 19 March 2018
Accepted: 2 January 2019
First Online: 19 January 2019
Compliance with ethical standards
:
: The study was designed in compliance with the principles of the Declaration of Helsinki and approved by the local ethics committee. For this type of study, formal consent is not required.
: Mehdi Shajari: Oculus, Zeiss, Staar, Santen, Oertli. Vladimir Rusev: none. Wolfgang Mayer: Consultant or Advisory Board—Alcon, Allergan, Polytech/Domilens, Zeiss Meditec, Ziemer. Vasilios Diakonis: none. Kerstin Petermann: none. Thomas Kohnen: Research Funding—Hoya, J&J Vision (Abbott), Novartis (Alcon), Oculentis, Oculus, Schwind, Zeiss. Consultant or Advisory Board—Geuder, J&J Vision (Abbott), Novartis (Alcon), Oculus, Santen, Schwind, STAAR, TearLab, Thea Pharma, Thieme Compliance, Ziemer, Zeiss. <i>Consultant and Research for</i> Abbott/J&J, Alcon/Novartis, Schwind, Zeiss. <i>Consultant for</i> Allergan, Bausch & Lomb, Dompe, Geuder, Med Update, Oculentis, Oculus, Rayner, Santen, Staar, Thea, Tear Lab, Thieme, Unimed Verlag, Ziemer. <i>Research for</i> Avedro, Hoya, Presbia.The authors declare that they have no conflict of interest.